heng Mei
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
7
7
0
N/A
0
3
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (7)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Hongmei Jing
Peking University Third Hospital
Shared therapeutic areas:
Worked with same sponsors:
depei wu
The First Affiliated Hospital of Soochow University
Shared therapeutic areas:
Worked with same sponsors:
Weili Zhao, PhD
Ruijin Hospital
Shared therapeutic areas:
Worked with same sponsors:
Huiqiang Huang, PhD
Sun Yat-sen University
Shared therapeutic areas:
Worked with same sponsors:
Dehui Zou
Hematology Hospital, Chinese Academy of Medical Sciences
Shared therapeutic areas:
Worked with same sponsors:
Zhifeng Li
The First Hospital of Xiamen University
Shared therapeutic areas:
Worked with same sponsors:
Qingyuan Zhang
Harbin Medical University Tumor Hospital
Shared therapeutic areas:
Worked with same sponsors:
liangjing Lv
Renji Hospital Shanghai Jiaotong University School of Medical
Shared therapeutic areas:
Worked with same sponsors:
Jianqiu Wu
Jiangsu Provincial Tumor Hospital
Shared therapeutic areas:
Worked with same sponsors:
Liang Huang, PhD
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (7)
Showing 7 of 7 trials
IASO-782 in Autoimmune Hematological Diseases
A Clinical Study to Evaluate the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Received Three or More Lines of Therapy
CD19-CART(Relma-cel) for Moderate to Severe Active Systemic Lupus Erythematosus
Relmacabtagene Autoleucel in Patients With LBCL
Anti-FLT3 CAR-T Cell (TAA05 Cell Injection) in the Treatment of Relapsed / Refractory Acute Myeloid Leukemia
Anti-CD7 CAR-Engineered T Cells for T Lymphoid Malignancies Malignancies
Sequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITP
All 7 trials loaded